Showing 1 - 10 results of 10 for search 'Prudence Ive', query time: 0.03s
Refine Results
-
1
Giant bacillary angiomatosis by Jeremy Nel, Prudence Ive, Carolina Nel
Published 2021-07-01
Article -
2
-
3
Tuberculosis Therapy Modifies the Cytokine Profile, Maturation State, and Expression of Inhibitory Molecules on Mycobacterium tuberculosis-Specific CD4+ T-Cells. by Kapil K Saharia, Constantinos Petrovas, Sara Ferrando-Martinez, Manuel Leal, Rafael Luque, Prudence Ive, Anne Luetkemeyer, Diane Havlir, Richard A Koup
Published 2016-01-01
Article -
4
Predictors of switch to and early outcomes on third-line antiretroviral therapy at a large public-sector clinic in Johannesburg, South Africa by Denise Evans, Kamban Hirasen, Rebecca Berhanu, Given Malete, Prudence Ive, David Spencer, Sharlaa Badal-Faesen, Ian M. Sanne, Matthew P. Fox
Published 2018-04-01
Article -
5
Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial. by Prudence Ive, William MacLeod, Nompumelelo Mkumla, Catherine Orrell, Ute Jentsch, Carole L Wallis, Wendy Stevens, Robin Wood, Ian Sanne, Debika Bhattacharya
Published 2013-01-01
Article -
6
Identification of a 251 gene expression signature that can accurately detect M. tuberculosis in patients with and without HIV co-infection. by Noor Dawany, Louise C Showe, Andrew V Kossenkov, Celia Chang, Prudence Ive, Francesca Conradie, Wendy Stevens, Ian Sanne, Livio Azzoni, Luis J Montaner
Published 2014-01-01
Article -
7
Developing a predictive risk model for first‐line antiretroviral therapy failure in South Africa by Julia K Rohr, Prudence Ive, C Robert Horsburgh, Rebecca Berhanu, Kate Shearer, Mhairi Maskew, Lawrence Long, Ian Sanne, Jean Bassett, Osman Ebrahim, Matthew P Fox
Published 2016-01-01
Article -
8
Marginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa. by Julia K Rohr, Prudence Ive, C Robert Horsburgh, Rebecca Berhanu, Kate Shearer, Mhairi Maskew, Lawrence Long, Ian Sanne, Jean Bassett, Osman Ebrahim, Matthew P Fox
Published 2016-01-01
Article -
9
Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance by Seth C. Inzaule, Cissy M. Kityo, Margaret Siwale, Alani Sulaimon Akanmu, Maureen Wellington, Marleen de Jager, Prudence Ive, Kishor Mandaliya, Wendy Stevens, T. Sonia Boender, Pascale Ondoa, Kim C. E. Sigaloff, Denise Naniche, Tobias F. Rinke de Wit, Raph L. Hamers
Published 2018-10-01
Article -
10
Southern African HIV Clinicians Society guideline for the prevention, diagnosis and management of cryptococcal disease among HIV-infected persons: 2019 update by Nelesh P. Govender, Graeme Meintjes, Phetho Mangena, Jeremy Nel, Samantha Potgieter, Denasha Reddy, Helena Rabie, Douglas Wilson, John Black, David Boulware, Tom Boyles, Tom Chiller, Halima Dawood, Sipho Dlamini, Thomas S. Harrison, Prudence Ive, Joseph Jarvis, Alan Karstaedt, Matamela C. Madua, Colin Menezes, Mahomed-Yunus S. Moosa, Zaaheera Motlekar, Amir Shroufi, Sarah L. Stacey, Merika Tsitsi, Gilles van Cutsem, Ebrahim Variava, Michelle Venter, Rachel Wake
Published 2019-11-01
Article